[go: up one dir, main page]

DK468186A - POLYXYGENERATED LABDAN DERIVATIVES, THEIR PREPARATION AND APPLICATION - Google Patents

POLYXYGENERATED LABDAN DERIVATIVES, THEIR PREPARATION AND APPLICATION Download PDF

Info

Publication number
DK468186A
DK468186A DK468186A DK468186A DK468186A DK 468186 A DK468186 A DK 468186A DK 468186 A DK468186 A DK 468186A DK 468186 A DK468186 A DK 468186A DK 468186 A DK468186 A DK 468186A
Authority
DK
Denmark
Prior art keywords
polyxygenerated
preparation
application
derivatives
labdan
Prior art date
Application number
DK468186A
Other languages
Danish (da)
Other versions
DK468186D0 (en
Inventor
Yatendra Khandelwal
Ramanujam Rajgopalan
Alihussein Nomanbha Dohadwalla
Richard Helmut Rupp
Souza Noel John De
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK468186D0 publication Critical patent/DK468186D0/en
Publication of DK468186A publication Critical patent/DK468186A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Polyoxygenated labdane derivatives which carry one or more aminoacyl groups as substituents are suitable, due to their pharmacological properties, for use in the treatment of cardiac and circulatory diseases, hypertension, glaucoma, allergies, broncho- constriction and as immunomodulators.
DK468186A 1985-10-02 1986-10-01 POLYXYGENERATED LABDAN DERIVATIVES, THEIR PREPARATION AND APPLICATION DK468186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853535086 DE3535086A1 (en) 1985-10-02 1985-10-02 NEW POLYOXYGENATED LABDAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINES

Publications (2)

Publication Number Publication Date
DK468186D0 DK468186D0 (en) 1986-10-01
DK468186A true DK468186A (en) 1987-04-03

Family

ID=6282512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK468186A DK468186A (en) 1985-10-02 1986-10-01 POLYXYGENERATED LABDAN DERIVATIVES, THEIR PREPARATION AND APPLICATION

Country Status (14)

Country Link
EP (1) EP0217372B1 (en)
JP (1) JPS6289677A (en)
KR (1) KR870004051A (en)
AT (1) ATE60054T1 (en)
AU (1) AU606036B2 (en)
DE (2) DE3535086A1 (en)
DK (1) DK468186A (en)
ES (1) ES2019863B3 (en)
GR (1) GR3001559T3 (en)
HU (1) HU203234B (en)
IL (1) IL80201A0 (en)
IN (2) IN163242B (en)
PT (1) PT83478B (en)
ZA (1) ZA867495B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE62683T1 (en) * 1985-03-01 1991-05-15 Hoechst Roussel Pharma LABDAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
US4963537A (en) * 1985-03-01 1990-10-16 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
JPS6310783A (en) * 1985-11-15 1988-01-18 Nippon Kayaku Co Ltd Novel forskolin derivative
DE3623300A1 (en) * 1986-07-11 1988-01-21 Hoechst Ag 7-ACYLOXY-6-AMINOACYLOXYPOLYOXYLABDANE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
IN166900B (en) * 1987-06-03 1990-08-04 Hoechst India
JPH0684367B2 (en) * 1987-06-29 1994-10-26 日本化薬株式会社 New method for producing forskolin derivative
JP2504934B2 (en) * 1987-06-29 1996-06-05 日本化薬株式会社 1,6,7-Triacylforskolin derivative
US4902696A (en) * 1987-10-08 1990-02-20 Hoechst-Roussel Pharmaceuticals, Inc. Synergistic intraocular pressure lowering combinations
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
EP0447962A1 (en) * 1990-03-17 1991-09-25 Hoechst Aktiengesellschaft Labdanes and process for their preparation
KR920002574A (en) * 1990-07-24 1992-02-28 이젠브루크, 라피체 Process for preparing 6- (3-substituted aminopropionyl) -7-deacetylphospholine derivatives
JP3557095B2 (en) * 1998-04-20 2004-08-25 高砂香料工業株式会社 Melanin production inhibitor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (en) 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, process for obtaining it and pharmaceutical preparations containing this compound
DE2640275A1 (en) 1976-09-08 1978-03-09 Hoechst Ag PHARMACOLOGICALLY EFFECTIVE SUBSTANCE FROM LABIATS
DE2654796A1 (en) * 1976-12-03 1978-06-08 Hoechst Ag POLYOXYGENATED LABDAN DERIVATIVES
FR2460397A1 (en) * 1979-07-05 1981-01-23 Ducellier & Cie ELECTRIC STARTER FOR INTERNAL COMBUSTION ENGINES IN PARTICULAR MOTOR VEHICLES
DE3581725D1 (en) * 1984-12-14 1991-03-14 Hoechst Roussel Pharma AMINOACYLLABDANE, METHOD AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
DE3502685A1 (en) 1985-01-26 1986-09-04 Hoechst Ag, 6230 Frankfurt FORSKOLIN, ITS ANALOGS AND DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF BY MEANS OF MICROBIAL CONVERSIONS AND THE USE OF THESE COMPOUNDS AS MEDICINAL PRODUCTS
US4639443A (en) * 1985-03-01 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
ATE62683T1 (en) * 1985-03-01 1991-05-15 Hoechst Roussel Pharma LABDAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives

Also Published As

Publication number Publication date
IL80201A0 (en) 1986-12-31
PT83478A (en) 1986-11-01
EP0217372B1 (en) 1991-01-16
KR870004051A (en) 1987-05-07
JPS6289677A (en) 1987-04-24
IN163242B (en) 1988-08-27
ATE60054T1 (en) 1991-02-15
AU606036B2 (en) 1991-01-31
DE3676922D1 (en) 1991-02-21
AU6327086A (en) 1987-04-09
DK468186D0 (en) 1986-10-01
ZA867495B (en) 1987-05-27
PT83478B (en) 1989-05-31
GR3001559T3 (en) 1992-11-23
EP0217372A2 (en) 1987-04-08
DE3535086A1 (en) 1987-04-16
IN164680B (en) 1989-05-06
HU203234B (en) 1991-06-28
EP0217372A3 (en) 1988-03-30
HUT46319A (en) 1988-10-28
ES2019863B3 (en) 1991-07-16

Similar Documents

Publication Publication Date Title
DK468186A (en) POLYXYGENERATED LABDAN DERIVATIVES, THEIR PREPARATION AND APPLICATION
YU47308B (en) SUBSTITUTED FLAVONOIDS, THEIR SALTS AND THE PROCEDURE FOR THEIR PRODUCTION
NO904666L (en) CONDENSED POLYCYCLIC COMPOUNDS, PROCEDURES PREPARING THEM AND APPLICATION AS PAF ANTAGONISTS, ANTIHISTAMINES AND / OR ANTI-INFLAMMATORY AGENTS.
DE3670841D1 (en) PYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
SE7613588L (en) PROCEDURE FOR PREPARATION OF 3,4-DIHYDRO-CHINAZOLINE DERIVATIVES
FR2426682A1 (en) DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING IT
ES2059534T3 (en) NEW BENZOPYRAN DERIVATIVES ANTI-HYPERTENSIVES.
DK381189D0 (en) N-2,3-BUTADIENYL-TRI- AND TETRAAMINOALKANDER DERIVATIVES AND THEIR USE
SE8006294L (en) 8-aminoalkyl-4-ALKYLPSORALENER
ES2016464A6 (en) Therapeutic uses of 2',5'-oligoadenylate derivatives.
DK0566567T3 (en) Antihypertensive benzopyran derivatives
SE7904216L (en) DI-O-N-ALKYLGYCEROL DERIVATIVES WITH IMMUNITY STIMULATING EFFECTS
SE8501882D0 (en) PYRIDINE DERIVATIVES AND PREPARATION THEREOF
ATE83481T1 (en) FIVE-MEMBERED HETEROCYCLIC DERIVATIVES OF N'SUBSTITUTEN,N'-DIACYLHYDRAZINES.
DE3576689D1 (en) OXA AND THIADIAZOLYL DERIVATIVES AND THEIR USE.
ES2029791T3 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZINE DERIVATIVES.
FR2539415B1 (en) IMIDAZOLINE D-2 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ATE15894T1 (en) HETEROCYCLIC DERIVATIVES OF AMIDOXINS, THEIR PRODUCTION AND THERAPEUTIC USE.
ATE99687T1 (en) STROBILURIN DERIVATIVES, THEIR PRODUCTION AND USE.
DK478485A (en) 4-OXO-PYRIDO (2,3-D) PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND USE
NO911798D0 (en) 3'-DEAMINO-4'-DEOXY-4'-AMINO-8-FLUORANTRACYCLINES AND THEIR PREPARATION.
SE8201308D0 (en) ALKYLENDIAMINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
FR2362865A1 (en) 2,2'-CYCLOCYTIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES AS ANTI-CANCER AGENTS
ATE44144T1 (en) 6H-DIBENZO(B,E)(1,4)OXATHIEPIN COMPOUNDS.
NO870515D0 (en) ESTERS OF N-ALKYL-NORTROPINES, DERIVATIVES THEREOF AND THEIR PREPARATION.